Effect of megestrol acetate on weight loss induced by tumour necrosis factor a and a cachexia-inducing tumour (MAC16) in NMRI mice
1990

Megestrol Acetate and Weight Loss in Mice

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): S.A. Beck, M.J. Tisdale

Primary Institution: Pharmaceutical Sciences Institute, Aston University

Hypothesis

Does megestrol acetate prevent weight loss induced by tumor necrosis factor and cachexia-inducing tumors in mice?

Conclusion

Megestrol acetate effectively prevents weight loss in mice induced by tumor necrosis factor and cachexia-inducing tumors, primarily by increasing food and water intake.

Supporting Evidence

  • Megestrol acetate increased food and water intake in treated mice.
  • Weight gain in treated mice was primarily due to increased water content.
  • Administration of megestrol acetate did not reverse weight loss in pair-fed animals.

Takeaway

This study shows that a medicine called megestrol acetate can help mice gain weight when they are losing it because of cancer-related issues.

Methodology

Female NMRI mice were treated with megestrol acetate and monitored for weight, food, and water intake over a 7-day period.

Potential Biases

Potential bias due to the lack of blinding in treatment administration.

Limitations

The study was conducted only on female mice, which may limit the generalizability of the results.

Participant Demographics

Female NMRI mice, aged 6 to 8 weeks.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication